Jones G R, Gemmell C G
J Med Microbiol. 1982 Aug;15(3):351-61. doi: 10.1099/00222615-15-3-351.
The ability of human polymorphonuclear leucocytes to phagocytose and kill Proteus mirabilis was impaired in vitro when the human serum, used to opsonise the target bacteria, was pretreated with cultures of various Bacteroides species. Live and dead, either heat-killed or clindamycin-treated, bacteroides cells elicited the same phenomenon. When bacteroides-treated serum was used to opsonise different Proteus species, the subsequent uptake of all strains by polymorphonuclear leucocytes was inhibited, whereas bacteroides-treated serum inhibited the uptake of some but not all of the test strains of Escherichia coli. The opsonic activity of untreated human serum was reduced when the classical complement pathway was inhibited by ethyleneglycol-bis-(beta-aminoethyl ether)N,N'-tetra-acetic acid (EGTA); subsequent treatment with bacteroides did not further reduce the opsonic activity of the serum for P. mirabilis.
当用于调理靶细菌的人血清用各种拟杆菌属菌种的培养物进行预处理时,人多形核白细胞吞噬和杀死奇异变形杆菌的能力在体外受到损害。活的和死的,无论是热灭活的还是经克林霉素处理的拟杆菌细胞都引发了相同的现象。当用经拟杆菌处理的血清调理不同的变形杆菌菌种时,多形核白细胞随后对所有菌株的摄取均受到抑制,而经拟杆菌处理的血清则抑制了部分但并非所有大肠杆菌测试菌株的摄取。当经典补体途径被乙二醇双(β-氨基乙醚)N,N'-四乙酸(EGTA)抑制时,未处理的人血清的调理活性降低;随后用拟杆菌进行处理并未进一步降低血清对奇异变形杆菌的调理活性。